Evolution of myeloid-mediated immunotherapy resistance in prostate cancer.
Lyu A, Fan Z, Clark M, Lea A, Luong D, Setayesh A, Starzinski A, Wolters R, Arias-Badia M, Allaire K, Wu K, Gurunathan V, Valderrábano L, Wei XX, Miller RA, Van Allen EM, Fong L.
Lyu A, et al. Among authors: wu k.
Nature. 2024 Dec 4. doi: 10.1038/s41586-024-08290-3. Online ahead of print.
Nature. 2024.
PMID: 39633050